2.71
전일 마감가:
$2.73
열려 있는:
$2.72
하루 거래량:
150.59K
Relative Volume:
0.46
시가총액:
$146.22M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-1.8067
EPS:
-1.5
순현금흐름:
$-46.21M
1주 성능:
-1.09%
1개월 성능:
+0.00%
6개월 성능:
-35.93%
1년 성능:
-50.82%
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
OBIO을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
OBIO
Orchestra Biomed Holdings Inc
|
2.71 | 147.30M | 2.76M | -49.12M | -46.21M | -1.50 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.48 | 101.34B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
482.13 | 59.64B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
556.53 | 59.19B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
767.00 | 47.00B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
351.13 | 38.12B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-08-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
2025-03-20 | 개시 | BTIG Research | Buy |
2025-01-02 | 개시 | Barclays | Overweight |
2024-08-22 | 개시 | H.C. Wainwright | Buy |
2024-07-25 | 개시 | B. Riley Securities | Buy |
2024-01-19 | 개시 | Jefferies | Buy |
2023-02-24 | 개시 | Piper Sandler | Overweight |
2023-02-07 | 개시 | Chardan Capital Markets | Buy |
모두보기
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
What technical models suggest about Orchestra BioMed Holdings Inc.’s comeback2025 Institutional Moves & Real-Time Stock Movement Alerts - Newser
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.July 2025 Closing Moves & Real-Time Buy Zone Alerts - Newser
has orchestra biomed holdings inc. formed a bullish divergenceGold Moves & High Accuracy Investment Signals - Newser
Why Orchestra BioMed Holdings Inc. is moving todaySwing Trade & Real-Time Volume Triggers - Newser
What indicators show strength in Orchestra BioMed Holdings Inc.Market Activity Report & Weekly Return Optimization Plans - Newser
Using portfolio simulators with Orchestra BioMed Holdings Inc. includedMarket Movers & Real-Time Buy Zone Alerts - Newser
Does Orchestra BioMed Holdings Inc. fit your quant trading modelEarnings Recap Summary & Smart Money Movement Alerts - Newser
Has Orchestra BioMed Holdings Inc. formed a bullish divergenceTrade Risk Assessment & Weekly High Conviction Ideas - Newser
Volatility clustering patterns for Orchestra BioMed Holdings Inc.Earnings Overview Summary & Weekly Watchlist for Consistent Profits - Newser
Analyzing Orchestra BioMed Holdings Inc. with risk reward ratio chartsGap Down & Community Driven Trade Alerts - Newser
Is it time to cut losses on Orchestra BioMed Holdings Inc.M&A Rumor & AI Enhanced Market Trend Forecasts - Newser
How to read the order book for Orchestra BioMed Holdings Inc.July 2025 Summary & Reliable Volume Spike Alerts - Newser
What the charts say about Orchestra BioMed Holdings Inc. today2025 Top Gainers & Free Weekly Watchlist of Top Performers - Newser
Orchestra BioMed Holdings Inc. Attempts Reversal From Key SupportTrade Exit Report & Daily Stock Trend Watchlist - beatles.ru
Orchestra BioMed Secures $111M to Advance Late-Stage Cardiac Therapies, Hits Multiple FDA Milestones - MSN
Orchestra BioMed Reports Long-Term Data Supporting AVIM Therapy for Hypertension - MyChesCo
Published on: 2025-09-08 17:50:40 - beatles.ru
Using data models to predict Orchestra BioMed Holdings Inc. stock movementWeekly Stock Summary & Community Driven Trade Alerts - Newser
Real time scanner hits for Orchestra BioMed Holdings Inc. explained - Newser
Is a relief rally coming for Orchestra BioMed Holdings Inc. holders2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Will Orchestra BioMed Holdings Inc. bounce back from current supportJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Historical volatility pattern of Orchestra BioMed Holdings Inc. visualizedPortfolio Gains Summary & Target Return Focused Stock Picks - Newser
Can Orchestra BioMed Holdings Inc. be the next market leaderOil Prices & High Return Stock Watch Alerts - beatles.ru
Long term hold vs stop loss in Orchestra BioMed Holdings Inc.Weekly Trade Analysis & Reliable Entry Point Alerts - Newser
Will Orchestra BioMed Holdings Inc. Recover After Recent Decline2025 Analyst Calls & AI Powered Market Trend Analysis - beatles.ru
Detecting price anomalies in Orchestra BioMed Holdings Inc. with AIQuarterly Portfolio Review & AI Driven Price Predictions - Newser
Analyzing net buyer seller activity in Orchestra BioMed Holdings Inc.Bull Run & Daily Stock Momentum Reports - Newser
What is Orchestra BioMed Holdings Inc. s P E ratio telling usMarket Risk Report & Daily Oversold Stock Bounce Ideas - خودرو بانک
Technical signs of recovery in Orchestra BioMed Holdings Inc.Weekly Volume Report & Entry Point Confirmation Signals - Newser
Understanding Orchestra BioMed Holdings Inc.’s price movementInsider Buying & Reliable Momentum Entry Alerts - Newser
Is Orchestra BioMed Holdings Inc.’s ROE strong enoughWeekly Profit Analysis & Weekly Stock Breakout Alerts - خودرو بانک
How much upside does Orchestra BioMed Holdings Inc. haveJuly 2025 Trends & Expert Approved Trade Ideas - خودرو بانک
Medtronic (MDT) Collaborates with Orchestra BioMed on Promising AVIM Therapy - GuruFocus
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout - Investing News Network
8.9mmHg Blood Pressure Drop Sustained for 3.6 Years: Orchestra BioMed's AVIM Therapy Shows Promise for Millions - Stock Titan
Orchestra BioMed stock price target lowered to $10 at H.C. Wainwright By Investing.com - Investing.com South Africa
Orchestra BioMed stock price target lowered to $10 at H.C. Wainwright - Investing.com Australia
Technical signs of recovery in Orchestra BioMed Holdings Inc2025 Analyst Calls & AI Driven Stock Reports - Newser
Published on: 2025-09-04 04:14:44 - Newser
Can volume confirm reversal in Orchestra BioMed Holdings Inc.Portfolio Value Report & AI Powered Buy/Sell Recommendations - Newser
Using data tools to time your Orchestra BioMed Holdings Inc. exitQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Can you recover from losses in Orchestra BioMed Holdings Inc.Quarterly Market Summary & Weekly Chart Analysis and Trade Guides - Newser
Comparing Orchestra BioMed Holdings Inc. in custom built stock radarsWeekly Trade Summary & Growth-Oriented Investment Plans - Newser
Orchestra Biomed Collects New Proceeds for Hypertension Study Enrollment - Medical Product Outsourcing
How cyclical is Orchestra BioMed Holdings Inc.’s revenue streamJuly 2025 Pullbacks & AI Powered Trade Plan Recommendations - خودرو بانک
Published on: 2025-09-03 05:17:06 - Newser
Is Orchestra BioMed Holdings Inc. stock forming a triangle pattern2025 Sector Review & Weekly Setup with ROI Potential - خودرو بانک
Published on: 2025-09-03 08:30:17 - خودرو بانک
Chart overlay techniques for tracking Orchestra BioMed Holdings Inc.July 2025 Summary & Stock Timing and Entry Methods - Newser
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Orchestra Biomed Holdings Inc 주식 (OBIO) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Sherman Darren | See Remarks |
Aug 25 '25 |
Buy |
2.62 |
3,000 |
7,860 |
926,837 |
Hochman David P | See Remarks |
Aug 21 '25 |
Buy |
2.49 |
6,000 |
14,940 |
651,460 |
Taylor Andrew Lawrence | Chief Financial Officer |
Aug 25 '25 |
Buy |
2.55 |
2,000 |
5,100 |
482,788 |
PERCEPTIVE ADVISORS LLC | 10% Owner |
Aug 01 '25 |
Buy |
2.75 |
700,000 |
1,925,000 |
5,292,556 |
Hochman David P | See Remarks |
Aug 04 '25 |
Buy |
2.75 |
20,000 |
55,000 |
349,331 |
Fain Eric S | Director |
Jun 26 '25 |
Sale |
3.05 |
2,683 |
8,183 |
50,949 |
자본화:
|
볼륨(24시간):